Pharvaris Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	1,257	1,150	380	477
Market Cap Growth	-	202.44%	-20.27%	-
Enterprise Value	838	715	208	239
PE Ratio	-10.26	-10.26	-4.68	-9.82
PB Ratio	3.06	2.69	2.39	2.05
P/FCF Ratio	-11.11	-11.11	-5.31	-9.38
P/OCF Ratio	-11.12	-11.12	-5.32	-9.41
EV/EBITDA Ratio	-6.66	-6.66	-2.26	-3.89
EV/EBIT Ratio	-6.64	-6.64	-2.26	-3.89
EV/FCF Ratio	-6.91	-6.91	-2.91	-4.70
Debt / Equity Ratio	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.00	0.00	-0.01	0.00
Debt / FCF Ratio	0.00	0.00	-0.01	-0.01
Interest Coverage	-33.27	-33.27	-	-
Return on Equity (ROE)	-48.00%	-48.00%	-42.70%	-19.50%
Return on Assets (ROA)	-44.60%	-44.60%	-39.20%	-18.80%
Return on Capital (ROIC)	-25.22%	-25.22%	-57.93%	-26.38%
Earnings Yield	-8.92%	-9.75%	-21.36%	-10.19%
FCF Yield	-7.93%	-9.00%	-18.83%	-10.66%
Buyback Yield / Dilution	-21.30%	-21.30%	-1.99%	-8.55%
Total Shareholder Return	-21.30%	-21.30%	-1.99%	-8.55%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).